Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
Recruiting
Observational Study
Streptococcus Infection
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 260 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Clindamycin is an antibiotic with several advantages: high oral bioavailability and good bone and joint penetration. In France, it is a recommended drug for other types of Streptococcus spp. osteoarticular infections and can be used as an alternative to amoxicillin for periprosthetic infections, including when implants are retained.
The hypothesis of this study is that clindamycin is no less effe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patient (aged 18 years or older) at the time of surgery for infection
* Probable or proven periprosthetic infection with Streptococcus spp. according to EBJIS diagnostic criteria
* Patient operated on in one of the associated centers between 2013 and 2024
Exclusion Crit…
Contacts